The silencing of B7-H3 expression through targeted antibodies resulted in a reduction in the CSC population, facilitated the activation of CD8+ T cells, and subsequently diminished tumor growth and lymph node metastasis in a mouse model of HNSCC. The gene discussed is CD276; the disease is head and neck squamous cell carcinoma.